Anti-citrullinated protein antibodies suppress let-7a expression in monocytes from patients with rheumatoid arthritis and facilitate the inflammatory responses in rheumatoid arthritis

Immunobiology. 2015 Dec;220(12):1351-8. doi: 10.1016/j.imbio.2015.07.007. Epub 2015 Jul 17.

Abstract

We hypothesized that anti-citrullinated protein antibodies (ACPAs) could affect the expression of miRNAs in monocytes and contribute to the inflammatory responses in rheumatoid arthritis (RA). The expression profiles of 270 human miRNAs, co-cultured with ACPAs or human immunoglobulin G (IgG), were analyzed using real-time polymerase chain reaction. Ten miRNAs exhibited differential expression in U937 cells after co-cultured with ACPAs compared with human IgG. The expression levels of these miRNAs were investigated in monocytes from 21 ACPA-positive RA patients and 13 controls. Among these miRNAs, the expression levels of let-7a was decreased in monocytes from ACPA-positive RA patients. The expression levels of let-7a showed a negative correlation with positivity of rheumatoid factor in patients sampled. We found that transfection of U937 cells with let-7a mimic suppressed K-Ras protein expression. In the ACPA-mediated signaling pathway, transfection of U937 cells with let-7a mimic suppressed the ACPA-enhanced phosphorylation of c-Jun N-terminal kinase (JNK), extracellular signal-regulated kinase 1/2 (ERK1/2), and the expression and secretion of interleukin (IL)-1β. In conclusion, ACPA-mediated decreased let-7a expression in monocytes from ACPA-positive RA patients. Decreased let-7a expression was associated with the positivity of RF in ACPA-positive RA patients. The decreased expression of let-7a could facilitate the inflammatory pathway via enhanced ACPA-mediated phosphorylation of ERK1/2 and JNK and increased expression of IL-1β through an increase in the expression of Ras proteins.

Keywords: Anti-citrullinated protein antibodies; MicroRNAs; Monocytes; Ras; Rheumatoid arthritis; let-7a.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Arthritis, Rheumatoid / genetics*
  • Arthritis, Rheumatoid / immunology*
  • Autoantibodies / immunology*
  • Biomarkers
  • C-Reactive Protein
  • Case-Control Studies
  • Cell Line
  • Cyclic AMP Response Element-Binding Protein / metabolism
  • Female
  • Gene Expression Profiling
  • Gene Expression Regulation*
  • Humans
  • Immunoglobulin G / blood
  • Immunoglobulin G / immunology
  • Interleukin-1beta / genetics
  • Interleukin-1beta / metabolism
  • JNK Mitogen-Activated Protein Kinases / metabolism
  • Male
  • MicroRNAs / genetics*
  • Middle Aged
  • Mitogen-Activated Protein Kinase 1 / metabolism
  • Mitogen-Activated Protein Kinase 3 / metabolism
  • Monocytes / immunology*
  • Monocytes / metabolism*
  • Phosphorylation
  • Proto-Oncogene Proteins c-jun / metabolism
  • Proto-Oncogene Proteins p21(ras) / genetics
  • Proto-Oncogene Proteins p21(ras) / metabolism
  • Rheumatoid Factor / blood
  • Transcriptome
  • U937 Cells

Substances

  • Autoantibodies
  • Biomarkers
  • Cyclic AMP Response Element-Binding Protein
  • Immunoglobulin G
  • Interleukin-1beta
  • KRAS protein, human
  • MicroRNAs
  • Proto-Oncogene Proteins c-jun
  • mirnlet7 microRNA, human
  • C-Reactive Protein
  • Rheumatoid Factor
  • JNK Mitogen-Activated Protein Kinases
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • Proto-Oncogene Proteins p21(ras)